Statistics

Total Visits

Views
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations45

File Visits

Downloads
1060.pdf56

Select a period of time:

Number of views in the range

Views
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations39

Number of downloads in the range

Downloads
1060.pdf54

Views

Views
December 20252
January 20266
February 20260
March 202616
April 20264
May 20267
June 20264
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • December 2025
    1
  • January 2026
    4
  • February 2026
    0
  • March 2026
    6
  • April 2026
    9
  • May 2026
    22
  • June 2026
    12
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States23
Spain5
Netherlands2
Argentina1
Benin1
Colombia1
Germany1
France1
Greece1
Kenya1
 

Top countries by downloads

Downloads
United States16
Netherlands4
Argentina4
Spain1
Colombia1
Kenya1
 

Top cities views

Views
San Jose6
Madrid5
Amsterdam1
Ankara1
Ashburn1
Athens1
Barranquilla1
Charlotte1
Dayton1
Ft. Washington1
 

Top cities by downloads

Downloads
Amsterdam2
Ashburn1